|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D12.2 |
Benign neoplasm of ascending colon
|
D122 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 16.59%
|
46.89%
|
20.26%
|
7.94%
|
3.75%
|
1.90%
|
1.02%
|
0.59%
|
0.35%
|
0.22%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D12.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
50,239
|
111,045
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
29,353
|
1,119,625
|
|
45385
|
COLONOSCOPY W/LESION REMOVAL |
27,915
|
27,930
|
|
45380
|
COLONOSCOPY AND BIOPSY |
20,141
|
20,149
|
|
J7120
|
RINGERS LACTATE INFUSION |
9,402
|
11,537
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
8,094
|
8,096
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
7,637
|
33,528
|
|
J3010
|
FENTANYL CITRATE INJECTION |
7,086
|
11,216
|
|
J2001
|
LIDOCAINE INJECTION |
5,113
|
43,051
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
4,204
|
4,653
|
|
82962
|
GLUCOSE BLOOD TEST |
3,953
|
4,322
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
3,467
|
10,492
|
|
45381
|
COLONOSCOPY SUBMUCOUS NJX |
3,114
|
3,113
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
2,985
|
3,461
|
|
G0500
|
MOD SEDAT ENDO SERVICE >5YRS |
2,880
|
2,880
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,403
|
9,969
|
|
99153
|
MOD SED SAME PHYS/QHP EA |
2,205
|
3,594
|
|
45390
|
COLONOSCOPY W/RESECTION |
2,076
|
2,076
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
2,075
|
2,075
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,036
|
2,058
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D12.2 related to the following DRG Codes:
393-395
|
